| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
|
J Clin Invest
|
2008
|
5.96
|
|
2
|
The international position on laparoscopic liver surgery: The Louisville Statement, 2008.
|
Ann Surg
|
2009
|
5.33
|
|
3
|
Actual 10-year survival after resection of colorectal liver metastases defines cure.
|
J Clin Oncol
|
2007
|
4.95
|
|
4
|
A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.
|
Ann Surg
|
2006
|
3.34
|
|
5
|
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
|
Ann Surg
|
2008
|
3.16
|
|
6
|
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
|
Cancer
|
2003
|
2.96
|
|
7
|
Comparative genomic analysis of primary versus metastatic colorectal carcinomas.
|
J Clin Oncol
|
2012
|
2.74
|
|
8
|
Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.
|
J Gastrointest Surg
|
2003
|
2.36
|
|
9
|
Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy.
|
Ann Surg
|
2009
|
2.27
|
|
10
|
The impact of margins on outcome after hepatic resection for colorectal metastasis.
|
Ann Surg
|
2007
|
2.23
|
|
11
|
Impact of steatosis on perioperative outcome following hepatic resection.
|
J Gastrointest Surg
|
2003
|
2.05
|
|
12
|
Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer.
|
J Gastrointest Surg
|
2007
|
1.86
|
|
13
|
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
|
Ann Surg
|
2008
|
1.85
|
|
14
|
A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.
|
Ann Surg
|
2008
|
1.76
|
|
15
|
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
|
J Clin Oncol
|
2005
|
1.73
|
|
16
|
Laparoscopic adrenalectomy for isolated adrenal metastasis.
|
Ann Surg Oncol
|
2007
|
1.71
|
|
17
|
Outcome of patients with fibrolamellar hepatocellular carcinoma.
|
Cancer
|
2006
|
1.66
|
|
18
|
Management of primary liver sarcomas.
|
Cancer
|
2007
|
1.65
|
|
19
|
Caudate hepatectomy for cancer: a single institution experience with 150 patients.
|
J Am Coll Surg
|
2005
|
1.64
|
|
20
|
Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.
|
J Clin Oncol
|
2006
|
1.60
|
|
21
|
Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.
|
Ann Surg
|
2005
|
1.60
|
|
22
|
Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients.
|
J Gastrointest Surg
|
2003
|
1.56
|
|
23
|
Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents.
|
J Am Coll Surg
|
2007
|
1.52
|
|
24
|
Simple measurement of intra-abdominal fat for abdominal surgery outcome prediction.
|
Arch Surg
|
2010
|
1.52
|
|
25
|
Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
|
Ann Surg
|
2008
|
1.52
|
|
26
|
18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
|
J Am Coll Surg
|
2007
|
1.51
|
|
27
|
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.
|
J Clin Oncol
|
2009
|
1.50
|
|
28
|
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma.
|
Ann Surg
|
2005
|
1.49
|
|
29
|
Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases.
|
Ann Surg Oncol
|
2008
|
1.48
|
|
30
|
Extrahepatic bile duct carcinoid tumors: malignant biliary obstruction with a good prognosis.
|
J Am Coll Surg
|
2007
|
1.46
|
|
31
|
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy.
|
Ann Surg Oncol
|
2009
|
1.44
|
|
32
|
En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report.
|
Gynecol Oncol
|
2006
|
1.44
|
|
33
|
Surgical treatment of hepatocellular carcinoma: expert consensus statement.
|
HPB (Oxford)
|
2010
|
1.40
|
|
34
|
Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases.
|
J Am Coll Surg
|
2007
|
1.39
|
|
35
|
Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.
|
Ann Surg
|
2008
|
1.39
|
|
36
|
Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm.
|
J Am Coll Surg
|
2007
|
1.30
|
|
37
|
Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms.
|
J Am Coll Surg
|
2007
|
1.29
|
|
38
|
Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment.
|
Ann Surg
|
2011
|
1.24
|
|
39
|
Polypoid lesions of the gallbladder: diagnosis and followup.
|
J Am Coll Surg
|
2009
|
1.24
|
|
40
|
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
|
Ann Surg Oncol
|
2009
|
1.20
|
|
41
|
Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.
|
Ann Surg Oncol
|
2008
|
1.19
|
|
42
|
Resection of adrenocortical carcinoma liver metastasis: is it justified?
|
Ann Surg Oncol
|
2012
|
1.18
|
|
43
|
Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
|
Ann Surg Oncol
|
2006
|
1.17
|
|
44
|
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract.
|
J Exp Clin Cancer Res
|
2009
|
1.12
|
|
45
|
Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma.
|
J Am Coll Surg
|
2005
|
1.12
|
|
46
|
Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.
|
Ann Surg Oncol
|
2009
|
1.11
|
|
47
|
Patterns of recurrence after ablation of colorectal cancer liver metastases.
|
Ann Surg Oncol
|
2011
|
1.10
|
|
48
|
Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
|
J Vasc Interv Radiol
|
2005
|
1.10
|
|
49
|
Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation.
|
J Surg Oncol
|
2010
|
1.08
|
|
50
|
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
|
HPB (Oxford)
|
2013
|
1.08
|
|
51
|
Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma.
|
HPB (Oxford)
|
2009
|
1.06
|
|
52
|
Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas.
|
Surgery
|
2007
|
1.06
|
|
53
|
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
|
Ann Surg Oncol
|
2009
|
1.04
|
|
54
|
Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease.
|
Lancet Oncol
|
2009
|
1.04
|
|
55
|
Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases.
|
Arch Surg
|
2004
|
1.03
|
|
56
|
Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.
|
J Surg Oncol
|
2010
|
1.02
|
|
57
|
Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
|
Ann Surg Oncol
|
2006
|
1.02
|
|
58
|
Differential diagnosis of proximal biliary obstruction.
|
Surgery
|
2006
|
1.01
|
|
59
|
Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer?
|
J Am Coll Surg
|
2005
|
1.00
|
|
60
|
Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.
|
Ann Surg
|
2006
|
0.99
|
|
61
|
Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
|
Ann Surg Oncol
|
2012
|
0.98
|
|
62
|
Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer.
|
Gynecol Oncol
|
2005
|
0.97
|
|
63
|
CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.
|
J Vasc Interv Radiol
|
2011
|
0.96
|
|
64
|
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
|
J Gastrointest Surg
|
2006
|
0.95
|
|
65
|
Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer.
|
Arch Surg
|
2007
|
0.94
|
|
66
|
A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years.
|
Cancer
|
2009
|
0.93
|
|
67
|
The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
|
Surg Oncol Clin N Am
|
2007
|
0.89
|
|
68
|
Kinetics of liver volume changes in the first year after portal vein embolization.
|
Arch Surg
|
2010
|
0.88
|
|
69
|
Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention.
|
Ann Surg Oncol
|
2008
|
0.88
|
|
70
|
Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
|
Ann Surg Oncol
|
2013
|
0.87
|
|
71
|
Selective use of diagnostic laparoscopy prior to planned hepatectomy for patients with hepatocellular carcinoma.
|
Surgery
|
2004
|
0.86
|
|
72
|
Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer.
|
J Clin Oncol
|
2003
|
0.86
|
|
73
|
Resection of perihilar biliary schwannoma.
|
Surg Oncol
|
2011
|
0.85
|
|
74
|
Synchronous resection of primary and liver metastases for neuroendocrine tumors.
|
Ann Surg Oncol
|
2012
|
0.85
|
|
75
|
Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
|
Gynecol Oncol
|
2008
|
0.84
|
|
76
|
Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions.
|
HPB (Oxford)
|
2008
|
0.83
|
|
77
|
The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis.
|
Surgery
|
2011
|
0.82
|
|
78
|
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
|
Ann Surg Oncol
|
2015
|
0.82
|
|
79
|
Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.
|
PLoS One
|
2013
|
0.81
|
|
80
|
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.
|
Ann Surg Oncol
|
2013
|
0.79
|
|
81
|
Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases.
|
J Gastrointest Surg
|
2011
|
0.79
|
|
82
|
Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature.
|
Pancreas
|
2006
|
0.78
|
|
83
|
Management and extent of resection for intrahepatic cholangiocarcinoma.
|
Surg Oncol Clin N Am
|
2009
|
0.78
|
|
84
|
Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease.
|
Ann Surg Oncol
|
2009
|
0.77
|
|
85
|
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.
|
Anticancer Res
|
2013
|
0.77
|
|
86
|
Laparoscopic staging for liver, biliary, pancreas, and gastric cancer.
|
Curr Probl Surg
|
2007
|
0.77
|
|
87
|
Systemic therapy for patients with resectable hepatic colorectal metastases: improving patient selection.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
88
|
Current role of therapeutic laparoscopy and thoracoscopy in the management of malignancy: a review of trends from a tertiary care cancer center.
|
J Am Coll Surg
|
2007
|
0.77
|
|
89
|
Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy.
|
Ann Surg
|
2016
|
0.75
|
|
90
|
Staging stage IV colorectal cancer.
|
Ann Surg Oncol
|
2013
|
0.75
|
|
91
|
Hepatic arterial infusion chemotherapy for metastases from colorectal cancer: is it really the end of an era?
|
J Clin Oncol
|
2008
|
0.75
|
|
92
|
Liver resection. State of the art.
|
Chir Ital
|
2006
|
0.75
|
|
93
|
A 46-Year-Old Asian Woman With Liver Mass.
|
Semin Oncol
|
2015
|
0.75
|
|
94
|
Recurrence patterns of intraductal papillary mucinous neoplasms of the pancreas on enhanced computed tomography.
|
J Comput Assist Tomogr
|
2009
|
0.75
|
|
95
|
Image of the month. Papillary low-grade neuroendocrine tumor of the pancreas with pancreatic duct dilation.
|
Arch Surg
|
2005
|
0.75
|